Description
TESTO-MED
COMPOSITION
Each ml of product contains: Testosterone enanthate 188mg, cypionate 187mg, propionate 25mg.
PHARMACOLOGICAL ACTION
Testo-Med is an androgenic preparation for intramuscular administration containing three different esters of the natural hormone testosterone.
INDICATIONS
Testosterone replacement therapy in male hypogonadal disorders, for example:
1. After castration
2. Eunuchoidism
3. Hypopituitarism
CONTRAINDICATIONS
Known or suspected mammary or prostaticb16 carcinoma in the male. This medicine is intended for use in female patients.
CHARACTERISTIC
Testosterone is often used to promote growth of muscle, bones and other tissues as well because of its ability to increase cell growth and division by improved nitrogen balance. This is happening due to increased protein synthesis.
WARNINGS
Middle-aged and elderly males with angina pectoris or other severe circulatory disease should receive androgen treatment only under very careful supervision.
DOSAGE AND ADMINISTRATION
In general, dosage should be adjusted according the response of the individual patient. Usually, Testo-Med is administrated for male patients with dose between 400 2000mg/week. This product is highly not recommended for children or pregnant woman use.
SIDE EFFECTS AND SPECIAL PRECAUTIONS
The following adverse reactions have been associated with androgen therapy:
1. Priapism and other signs of excessive sexual stimulation.
2. In prepubertal boys: precocious sexual development, an increased frequency of erections, phallic enlargement and premature epiphyseal closure.
3. Oligospermia and decreased ejaculatory volume.
PRECAUTIONS
If androgen-associated adverse reaction occur, treatment should be interrupted and, after disappearance of the symptoms, be resumed at a lower dosage. Patients with latent or overt cardiac failure, renal dysfunction, hypertension, epilepsy or migraine (or a history of these conditions) should be monitored, since androgens may occasionally induce salt and fluid retention. Androgens should be used cautiously in prepubertal boys to avoid premature epiphyseal closure or precocious sexual development. A decrease in protein etvib bound iodine (PBI) may occur, but this has no clinical significance.
STORAGE
Store in a cool dry place. Protect from light.
Reviews
There are no reviews yet.